IGEA Pharma NV
SIX:IGPH

Watchlist Manager
IGEA Pharma NV Logo
IGEA Pharma NV
SIX:IGPH
Watchlist
Price: 0.0005 CHF Market Closed
Market Cap: 505.5k CHF

Relative Value

IGPH doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of IGPH.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IGPH Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.4
vs History
vs Industry
Median 3Y
0.4
Median 5Y
0.4
Industry
22.9
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-12.9
Industry
14.7
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-13.4
Industry
21.4
vs History
vs Industry
Median 3Y
-0.5
Median 5Y
-0.5
Industry
2.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.3
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-11.2
Industry
12.3
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-11.2
Industry
17.2
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-14.3
Industry
15
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-14.3
Industry
19
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-2.5
Industry
1.9

Multiples Across Competitors

IGPH Competitors Multiples
IGEA Pharma NV Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NL
IGEA Pharma NV
SIX:IGPH
505.5k CHF 0 0.4 -2.9 -2.9
US
Abbott Laboratories
NYSE:ABT
216.1B USD 4.9 15.5 19.7 27.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
201.4B USD 21 73.3 56.2 68.5
US
Boston Scientific Corp
NYSE:BSX
139.5B USD 7.2 50 29.3 39.8
US
Stryker Corp
NYSE:SYK
136B USD 5.6 46.2 22.6 27.3
IE
Medtronic PLC
NYSE:MDT
123.6B USD 3.6 25.9 14.6 21.2
DE
Siemens Healthineers AG
XETRA:SHL
52.2B EUR 2.2 24.3 13.7 19.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57.1B USD 13.7 55.6 39.9 44.2
US
Becton Dickinson and Co
NYSE:BDX
57.5B USD 2.6 34.3 12.6 21.5
US
Edwards Lifesciences Corp
NYSE:EW
48.7B USD 8.3 35.6 25.4 27.8
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.6B USD 1.9 17.4 13 15.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NL
IGEA Pharma NV
SIX:IGPH
Average EV/EBITDA: 24.7
Negative Multiple: -2.9
N/A N/A
US
Abbott Laboratories
NYSE:ABT
19.7
12%
1.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
56.2
26%
2.2
US
Boston Scientific Corp
NYSE:BSX
29.3
22%
1.3
US
Stryker Corp
NYSE:SYK
22.6
13%
1.7
IE
Medtronic PLC
NYSE:MDT
14.6
8%
1.8
DE
Siemens Healthineers AG
XETRA:SHL
13.7
11%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.9
14%
2.9
US
Becton Dickinson and Co
NYSE:BDX
12.6
9%
1.4
US
Edwards Lifesciences Corp
NYSE:EW
25.4
13%
2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
13
10%
1.3